Barrier, A <br/><br/>
[Jaw osteonecrosis induced by oral biphosphonates: 12 cases].  [electronic resource] 

 -  Revue de stomatologie et de chirurgie maxillo-faciale  Sep 2010 
 - 196-202 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1776-257X 
<br/><br/><label>Standard No.: </label>10.1016/j.stomax.2010.07.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alendronate--adverse effects<br/>Autoimmune Diseases--complications<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Chronic Disease<br/>Delayed Diagnosis<br/>Diphosphonates--administration & dosage<br/>Drug Therapy, Combination<br/>Etidronic Acid--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Jaw Diseases--chemically induced<br/>Male<br/>Mandibular Diseases--chemically induced<br/>Middle Aged<br/>Osteonecrosis--chemically induced<br/>Osteoporosis--drug therapy<br/>Risedronic Acid<br/>Time Factors<br/>Tooth Extraction<br/>Treatment Outcome